Compounding pharmacies, that produced the weight loss drugs at a fraction of their brand name price, are being forced to stop ...

GLP-1 stands for glucagon-like peptide-1, a satiety hormone the body produces when we eat to help stimulate digestion and ...

Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.

Patients taking weight-loss medicines such as Novo Nordisk A/S’s Ozempic and Wegovy are at risk of developing an eye ...

Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S.

A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.

The maker of weight loss drugs Ozempic and Wegovy broke rules around the advertising and marketing of its medication to ...